Status:

COMPLETED

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

Lead Sponsor:

Lantheus Medical Imaging

Conditions:

Ventricular Ejection Fraction

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular eje...

Eligibility Criteria

Inclusion

  • Adult subjects 18 years of age or older
  • Have a documented EF value ranging from 25% to 40%
  • Have been scheduled to undergo or have undergone a cardiac MRI study

Exclusion

  • Severe valvular dysfunction
  • Inability to remain supine for 30 minutes

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

131 Patients enrolled

Trial Details

Trial ID

NCT00401687

Start Date

July 1 2006

End Date

April 1 2008

Last Update

May 20 2011

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University of Arizona

Tucson, Arizona, United States, 85727

2

University of Chicago Medical Center

Chicago, Illinois, United States, 60637

3

Washington Hospital Center

Washington DC, Maryland, United States, 20010

4

Saint Lukes Mid America Heart Institute

Kansas City, Missouri, United States, 64111